Contact 
Locations .png){kind=icon}
Call Asthma Treatment
Asthma treatment aims to control day-to-day symptoms and reduce the future risk of attacks, lung-function loss, and medicine side effects. A clinician builds the plan around confirmed diagnosis, inhaled anti-inflammatory treatment, device technique, exposures, other health conditions, and regular review.
Clinic Information
These links provide location-specific planning information. Contact the office to confirm that the requested appointment type is currently offered there.
Confirm Control and Future Risk
What Guides an Asthma Treatment Plan
Control and future risk
Treatment decisions consider daytime symptoms, nighttime waking, rescue-medication use, activity limitation, lung function, prior emergency visits, oral steroid courses, intensive-care treatment, and known triggers. A person with few daily symptoms can still have important attack risk.
Shared treatment decisions
Before stepping treatment up, the clinician should review whether the diagnosis remains sound, whether the inhaler is being used correctly and consistently, and whether smoking, vaping, allergens, chronic sinus disease, reflux, medication access, or another condition is contributing.
Review the exercise asthma medication guide for symptom patterns, evaluation questions, management options, and reasons to seek specialist care.
Treat Airway Inflammation
Controller and Reliever Medication
Current guideline-based care includes an inhaled corticosteroid-containing strategy for most adolescents and adults with asthma, with age-appropriate plans for children. The exact controller and reliever approach depends on age, severity, prior response, insurance coverage, and the prescribing clinician’s assessment.
Long-acting bronchodilators are used in appropriate combinations, not as unsupervised substitutes for anti-inflammatory treatment. Repeated reliance on a short-acting rescue inhaler or frequent oral steroid courses is a reason to reassess control and risk.
Technique Changes Outcomes
Inhalers, Spacers, Adherence, and Access
Device technique
Inhalers differ in their design and instructions. A clinical review can include a demonstration with the device actually prescribed and an opportunity to ask about technique, cleaning and tracking use. Device-specific education comes from the care team.
Adherence and access
Tell the clinician about insurance questions, refill gaps, unwanted effects and practical barriers at work or school. The team can discuss how care is coordinated and direct coverage questions to the appropriate contact.
Escalate Only After Reassessment
Specialist Options and Biologic Therapy
For asthma that remains uncontrolled, the next step may include adjusting inhaled treatment, addressing a comorbidity, confirming the inflammatory pattern, or considering a targeted biologic. Eligibility depends on age, asthma severity, exacerbation history, biomarkers, allergic sensitization, medication adherence, and product-specific criteria.
Biologics are not interchangeable, do not cure asthma, and do not replace an emergency plan. Current availability and coverage must be confirmed. Maintenance treatment should not be stopped after improvement unless the prescribing clinician directs a monitored change.
When comparing options for the best pediatric pulmonology specialist, review the program’s age range, testing approach, follow-up plan, and access to urgent guidance.
Written Action Plans and Follow-Up
An asthma action plan is an individual clinical document. The treating team explains its instructions and reviews whether the current version matches the person's care. A general web page cannot complete or replace it. NHLBI provides background on written asthma action plans.
| Review topic | Question for the care team |
|---|---|
| Current version | Which clinician is responsible for reviewing the plan? |
| A recent emergency visit | How will the team review the discharge records and follow-up needs? |
| School or caregiver documents | Who needs the latest clinician-approved information? |
| Ongoing questions | Which contact handles routine clarification? |
Severe breathing difficulty requires emergency help through 911 rather than a future appointment. The asthma attack and follow-up article keeps that emergency route clear and explains the later coordination conversation.
Know When to Get Urgent Help
Emergency and Red-Flag Symptoms
Follow the written asthma action plan during a flare. Call 911 for severe breathing difficulty, blue or gray lips, confusion, fainting, difficulty speaking because of breathlessness, or symptoms that remain severe after prescribed rescue treatment. Do not drive yourself when breathing is dangerously impaired.
Patient Questions
Frequently Asked Questions
Guideline-based plans commonly include inhaled corticosteroid-containing treatment even when symptoms are infrequent, because attack risk and daily symptoms are not the same. The exact plan depends on age and clinical history.
Small technique errors can greatly reduce medication delivery. Demonstrating the device helps distinguish a treatment failure from a delivery problem.
Biologics are considered for selected patients with severe asthma after diagnosis, adherence, technique, exposures, and other conditions are reassessed. Eligibility is product- and patient-specific.
Do not stop controller treatment on your own. Improvement may mean the plan is working, and an unsupervised change can increase attack risk.
It should list daily treatment, worsening-symptom instructions, reliever use, clinician contact thresholds, and emergency warning signs in language the patient and caregivers can follow.
Patient guide
Asthma Treatment: decisions, preparation, and safety
Quick answer
Most asthma plans include an inhaled corticosteroid-containing treatment because airway inflammation can be present even when symptoms seem mild. The exact controller and reliever strategy, dose, device, and schedule must be selected for the individual patient.
Who may want to ask about it
A treatment review is useful for recurring cough, wheeze, chest tightness, shortness of breath, nighttime waking, exercise limitation, frequent reliever use, steroid courses, urgent visits, missed school or work, or uncertainty about the diagnosis or inhaler plan.
What the visit or test may answer
The clinician reviews symptom control and future risk, confirms inhaler technique and adherence, and may use spirometry or another objective measure. The visit also looks for triggers, work exposures, smoking or vaping, nasal disease, reflux, sleep problems, medication effects, and conditions that can mimic asthma.
How to prepare
Bring every inhaler, spacer, nebulizer medicine, and medication list; note refill gaps, urgent visits, oral steroid courses, nighttime symptoms, exercise limits, and possible exposures. Bring prior spirometry and the current written action plan if one exists.
Limits and safety
A webpage cannot safely choose an inhaler, change a dose, or tell a patient when to stop treatment. Reliever names and dosing differ across plans, so patients should follow the written instructions created for them and ask the clinician to reconcile any conflicting directions.
When symptoms need urgent care
Severe breathlessness, blue or gray lips, confusion, exhaustion, difficulty speaking, faintness, a rapidly worsening attack, or little response to the prescribed reliever requires the patient’s emergency plan and immediate care.
Alternatives to discuss
If asthma remains uncontrolled, the next step may be correcting technique or access, confirming adherence and diagnosis, reducing relevant exposure, treating a contributing condition, changing the inhaled strategy, or evaluating severe asthma and biologic eligibility.
A useful next step
Ask the clinician to demonstrate the inhaler, watch you use it, name the controller and reliever, explain the green, yellow, and red zones, define the follow-up goal, and provide one written plan that home, school, work, and caregivers can understand.
Treat Symptoms and Future Risk
Asthma control is more than how you feel today
Current asthma strategy separates two connected goals. Symptom control covers daytime symptoms, nighttime waking, activity limits, and reliever use. Future risk includes severe attacks, urgent care, oral corticosteroid exposure, medication side effects, and loss of lung function. A person can have few daily symptoms and still carry meaningful attack risk, so both parts belong in every review.
The clinician also confirms that asthma is the right diagnosis. Variable breathing symptoms and objective evidence of variable airflow limitation often support it, but vocal-cord or upper-airway problems, chronic cough from another cause, heart disease, deconditioning, anemia, reflux, and anxiety-related breathing can overlap. When the diagnosis is uncertain, spirometry or another planned test may be more useful than simply adding medicine.
Build an Anti-Inflammatory Plan
Why inhaled corticosteroid-containing care is central
GINA’s current strategy recommends that adults, adolescents, and children in the relevant age groups receive inhaled corticosteroid-containing treatment rather than relying on a short-acting bronchodilator alone. Inhaled corticosteroids address airway inflammation and reduce severe exacerbation risk. Different evidence-based pathways use different reliever and controller combinations, so a familiar inhaler name is not enough to identify the plan.
The clinician chooses a strategy based on age, symptom frequency, attack history, lung function, pregnancy, other conditions, device ability, access, cost, and preference. Patients should know which inhaler is the daily or maintenance medicine, which is the reliever, whether the same device serves both roles, the maximum use described in their plan, and what change triggers a call or urgent care. Medicine should not be changed from a general online step chart.
Make the Device Work
Inhaler technique, spacers, adherence, and access
An effective medicine cannot reach the lungs if the device is empty, poorly coordinated, used with the wrong breathing pattern, or not taken. Metered-dose inhalers, dry-powder inhalers, soft-mist inhalers, spacers, and nebulizers have different steps. Technique should be demonstrated, observed, and corrected with the patient’s own device at diagnosis and follow-up.
Adherence questions should be practical and nonjudgmental. Cost, refill timing, school rules, complex schedules, side effects, taste, fear of corticosteroids, hand strength, memory, transportation, and pharmacy supply can all interrupt treatment. A simpler or more affordable plan that can be followed may control asthma better than a theoretically stronger plan that never reaches the patient.
Reduce Modifiable Risk
Triggers, exposures, and health conditions that affect asthma
Asthma symptoms can worsen with viral infections, smoke, vaping, air pollution, allergens, exercise, cold air, occupational exposure, strong irritants, and some medicines. The goal is not to avoid all movement, outdoor life, pets, or ordinary activity. The clinician helps identify which exposures have credible evidence in the individual history and which targeted steps are realistic.
Rhinitis, chronic sinus disease, obesity, reflux, sleep apnea, anxiety or depression, pregnancy, and food allergy can affect risk or the experience of breathing symptoms. Treating every possible condition does not automatically improve asthma, but overlooking a relevant one can make control harder. Ask which factor is supported by the history and how improvement will be measured.
Use a Written Action Plan
Green, yellow, and red zones should lead to clear actions
A written asthma action plan translates the daily regimen and worsening symptoms into steps a patient can follow. It should identify usual treatment, the signs or measurements that define worsening, how to use the prescribed reliever, when to contact the clinical team, and when to seek emergency care. Children may need aligned copies for home, school, sports, and caregivers.
The plan should match the exact inhalers and current strategy. Old action plans can become unsafe when products, doses, or reliever roles change. At follow-up, review whether the yellow-zone instructions were understandable during a real flare and whether medicines were available where they were needed.
Review Before Stepping Up
What persistent symptoms or repeated attacks may mean
Before labeling asthma severe or escalating treatment, clinicians review diagnosis, technique, adherence, exposures, comorbidities, and whether the current plan was used consistently. If these are addressed and asthma remains uncontrolled, additional inhaled options or phenotype-directed treatment may be appropriate.
Severe asthma evaluation may include attack history, steroid burden, lung function, allergy status, eosinophils, exhaled nitric oxide, and other features. Biologic therapy targets specific pathways and approved indications; it is not selected from symptoms alone. Every step-up should include a response measure and a plan to review benefit, side effects, and the possibility of stepping down only after sustained control.
Compare the Options
What a complete asthma follow-up should review
A useful visit connects symptoms, future risk, technique, access, testing, and a written plan.
| Review area | Questions to answer | Possible next decision |
|---|---|---|
| Current control | Daytime symptoms, night waking, activity, and reliever use | Keep, adjust, or clarify the daily strategy |
| Future risk | Attacks, urgent care, oral steroids, lung function, smoking or vaping, and prior severe events | Reduce modifiable risk and consider a stronger prevention plan |
| Technique and access | Can the patient use and obtain the exact device consistently? | Retrain, add a spacer, simplify, or address cost and supply |
| Diagnosis and contributors | Do the pattern and objective findings fit asthma, and what else affects breathing? | Targeted testing or treatment of a supported contributor |
| Action plan | Are worsening and emergency instructions current and understandable? | Update written zones and share needed copies |
| Response | Did the last change improve the agreed outcome without unacceptable burden? | Continue, step up, refer, or consider a supervised step-down after control |
Patient questions
Frequently asked questions about Asthma Treatment
What is the main goal of asthma treatment?
The goals are good day-to-day symptom control and lower future risk of attacks, lung-function loss, and medication side effects while supporting normal activity.
Why are inhaled corticosteroids used for asthma?
They treat airway inflammation and reduce severe attack risk. Current strategy recommends corticosteroid-containing care for asthma rather than relying on a short-acting bronchodilator alone.
Is a rescue inhaler enough for mild asthma?
Current guidance emphasizes an inhaled corticosteroid-containing approach even when symptoms seem mild. The clinician should choose and explain the specific controller and reliever strategy.
How do I know whether my asthma is controlled?
Control includes daytime symptoms, night waking, activity limits, and reliever use, while risk includes attacks, steroid courses, urgent care, and lung function. A clinician reviews both.
Why does inhaler technique matter so much?
Each device needs a specific breathing and handling technique. Errors can leave most of the medicine in the mouth or device, making effective treatment appear to fail.
Should everyone with a metered-dose inhaler use a spacer?
A spacer can improve delivery and coordination for many metered-dose inhaler plans, but device needs differ. Ask the clinician or pharmacist to demonstrate the exact prescribed setup.
Can exercise make asthma worse?
Exercise can trigger symptoms when asthma is not well controlled, but the goal is usually safe, full activity rather than avoiding exercise. The clinician can assess control and create an activity plan.
What is an asthma action plan?
It is a written set of daily, worsening, and emergency instructions matched to the patient’s medicines and symptoms or measurements. It should be updated whenever the regimen changes.
When is asthma considered severe?
Severe asthma is a specialist determination made after confirming the diagnosis and addressing technique, adherence, exposures, and other conditions. It is not defined by one difficult week.
When are biologics considered for asthma?
They may be considered for selected patients whose asthma remains severe despite optimized care and whose clinical features match an approved targeted therapy. Evaluation is individualized.
Can asthma medicine be stopped when I feel better?
Feeling better may mean the plan is working. Any step-down should be planned with the clinician after sustained control and risk review rather than stopping treatment abruptly.
When is an asthma attack an emergency?
Severe difficulty breathing, blue or gray lips, confusion, exhaustion, trouble speaking, faintness, rapid worsening, or poor response to the prescribed reliever requires the emergency plan and immediate care.
Choose the right next step
Contact Modena Health with a specific care question, or review clinic information before planning a visit.
For coordinated evaluation and care information, start with an asthma and allergy center and choose the service path that matches your question.
Appointments & Insurance
Scheduling made easy for your experience.
We work with many major insurance carriers.
Don’t see your carrier?
Insurance participation varies by plan, provider, network, and location. Please contact our team with your insurance card to confirm current participation. View participating plans.
Ready to schedule?
Call us or submit an online appointment request.
Have questions about insurance?
Have your insurance card ready and our team can help confirm current participation.
Is this a medical emergency?
Call 911 and follow your prescribed emergency action plan. Please do not use this form for emergencies.
Request an AppointmentLive Well
Request a consultation with our team.
